US Patent 8293756 Pharmaceutical compositions comprising nilotinib hydrochloride monohydrate
Patent 8293756 was granted and assigned to Novartis on October, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8293756 Pharmaceutical compositions comprising nilotinib hydrochloride monohydrate
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
